Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1993 Aug;109(4):1219–1225. doi: 10.1111/j.1476-5381.1993.tb13752.x

Effects of NG-nitro-L-arginine methyl ester on the cardiovascular system of the anaesthetized rabbit and on the cardiovascular response to thyrotropin-releasing hormone.

E E Seligsohn 1, A Bill 1
PMCID: PMC2175768  PMID: 8401932

Abstract

1. The effects of 300 mg kg-1 of the nitric oxide (NO) inhibitor NG-nitro-L-arginine methyl ester (L-NAME) on the regional blood flow, on the flow response to 1 mg kg-1 of thyrotropin-releasing hormone (TRH) and on cerebral blood flow autoregulation were studied in urethane anesthetized rabbits subjected to unilateral sectioning of the cervical sympathetic claim. The blood flow measurements were performed by the tracer microspheres method. 2. The cerebral arteriovenous difference in oxygen saturation (CAVOD) was measured before and after the administration of L-NAME and TRH in order to ascertain whether the effects on cerebral blood flow that were observed were secondary to changes in cerebral metabolism. 3. L-NAME caused a significant decrease in blood flow in several cerebral regions; CBFtot decreased to 72 +/- 4% of control (P < 0.001). An increase in blood pressure and a concurrent decrease in heart rate and cardiac output were noted. 4. In the eye, L-NAME caused a reduction in uveal blood flow which was more pronounced on the sympathetically intact side; in the retina the blood flow decreased to 50% of control on both sides. 5. The administration of TRH in animals pretreated with L-NAME caused a significant increase in blood pressure and cerebral blood flow. 6. In L-NAME-treated animals the CBF was not affected when the mean arterial blood pressure was increased by ligation of the abdominal aorta. 7. The CAVOD increased from 56.0 +/- 5.2 to 73.6 +/- 3.5%, 20 min after the administration of L-NAME.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alm A., Bill A. The oxygen supply to the retina. II. Effects of high intraocular pressure and of increased arterial carbon dioxide tension on uveal and retinal blood flow in cats. A study with radioactively labelled microspheres including flow determinations in brain and some other tissues. Acta Physiol Scand. 1972 Mar;84(3):306–319. doi: 10.1111/j.1748-1716.1972.tb05182.x. [DOI] [PubMed] [Google Scholar]
  2. Bill A. Effects of acetazolamide and carotid occlusion on the ocular blood flow in unanesthetized rabbits. Invest Ophthalmol. 1974 Dec;13(12):954–958. [PubMed] [Google Scholar]
  3. Bredt D. S., Hwang P. M., Snyder S. H. Localization of nitric oxide synthase indicating a neural role for nitric oxide. Nature. 1990 Oct 25;347(6295):768–770. doi: 10.1038/347768a0. [DOI] [PubMed] [Google Scholar]
  4. Feuerstein G., Hassen A. H., Faden A. I. TRH: cardiovascular and sympathetic modulation in brain nuclei of the rat. Peptides. 1983 Sep-Oct;4(5):617–620. doi: 10.1016/0196-9781(83)90006-2. [DOI] [PubMed] [Google Scholar]
  5. González C., Estrada C. Nitric oxide mediates the neurogenic vasodilation of bovine cerebral arteries. J Cereb Blood Flow Metab. 1991 May;11(3):366–370. doi: 10.1038/jcbfm.1991.76. [DOI] [PubMed] [Google Scholar]
  6. Haefliger I. O., Flammer J., Lüscher T. F. Nitric oxide and endothelin-1 are important regulators of human ophthalmic artery. Invest Ophthalmol Vis Sci. 1992 Jun;33(7):2340–2343. [PubMed] [Google Scholar]
  7. Horita A., Carino M. A., Lai H. Pharmacology of thyrotropin-releasing hormone. Annu Rev Pharmacol Toxicol. 1986;26:311–332. doi: 10.1146/annurev.pa.26.040186.001523. [DOI] [PubMed] [Google Scholar]
  8. Hugoson-Seligsohn E. E., Koskinen L. O. TRH-induced blood flow and mean arterial pressure changes in the rabbit are not dependent on the anaesthetic used. Br J Pharmacol. 1989 May;97(1):190–196. doi: 10.1111/j.1476-5381.1989.tb11941.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hökfelt T., Fuxe K., Johansson O., Jeffcoate S., White N. Distribution of thyrotropin-releasing hormone (TRH) in the central nervous system as revealed with immunohistochemistry. Eur J Pharmacol. 1975 Dec;34(2):389–392. doi: 10.1016/0014-2999(75)90269-1. [DOI] [PubMed] [Google Scholar]
  10. Koskinen L. D., Sperber G. O. Regional glucose metabolism in the rabbit brain in control and TRH-treated animals. Acta Physiol Scand. 1986 Mar;126(3):349–353. doi: 10.1111/j.1748-1716.1986.tb07826.x. [DOI] [PubMed] [Google Scholar]
  11. Koskinen L. O., Bill A. Thyrotropin-releasing hormone (TRH) causes sympathetic activation and cerebral vasodilation in the rabbit. Acta Physiol Scand. 1984 Oct;122(2):127–136. doi: 10.1111/j.1748-1716.1984.tb07490.x. [DOI] [PubMed] [Google Scholar]
  12. Koskinen L. O. Cerebral and peripheral blood flow effects of TRH in the rat--a role of vagal nerves. Peptides. 1989 Sep-Oct;10(5):933–938. doi: 10.1016/0196-9781(89)90171-x. [DOI] [PubMed] [Google Scholar]
  13. Koskinen L. O. Effect of low intravenous doses of TRH, acid-TRH and cyclo(His-Pro) on cerebral and peripheral blood flows. Br J Pharmacol. 1986 Mar;87(3):509–519. doi: 10.1111/j.1476-5381.1986.tb10193.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Koskinen L. O. Effects of TRH on cerebral and peripheral blood flows; role of submesencephalic brain stem centres. Acta Physiol Scand. 1986 Oct;128(2):277–288. doi: 10.1111/j.1748-1716.1986.tb07976.x. [DOI] [PubMed] [Google Scholar]
  15. Koźniewska E., Oseka M., Styś T. Effects of endothelium-derived nitric oxide on cerebral circulation during normoxia and hypoxia in the rat. J Cereb Blood Flow Metab. 1992 Mar;12(2):311–317. doi: 10.1038/jcbfm.1992.43. [DOI] [PubMed] [Google Scholar]
  16. Lacolley P. J., Lewis S. J., Brody M. J. Role of sympathetic nerve activity in the generation of vascular nitric oxide in urethane-anesthetized rats. Hypertension. 1991 Jun;17(6 Pt 2):881–887. doi: 10.1161/01.hyp.17.6.881. [DOI] [PubMed] [Google Scholar]
  17. Leppäluoto J., Koivusalo F., Kraama R. Thyrotropin-releasing factor: distribution in neural and gastrointestinal tissues. Acta Physiol Scand. 1978 Oct;104(2):175–179. doi: 10.1111/j.1748-1716.1978.tb06264.x. [DOI] [PubMed] [Google Scholar]
  18. McCann M. J., Hermann G. E., Rogers R. C. Thyrotropin-releasing hormone: effects on identified neurons of the dorsal vagal complex. J Auton Nerv Syst. 1989 Mar;26(2):107–112. doi: 10.1016/0165-1838(89)90158-6. [DOI] [PubMed] [Google Scholar]
  19. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  20. Nurminen M. L. Intracerebroventricular immunization with TRH-antiserum lowers blood pressure in spontaneously hypertensive rats. Acta Physiol Scand. 1992 Jan;144(1):75–81. doi: 10.1111/j.1748-1716.1992.tb09269.x. [DOI] [PubMed] [Google Scholar]
  21. Okuda C., Mizobe T., Miyazaki M. Involvement of endogenous thyrotropin-releasing hormone in central regulation of the cardiovascular system after bleeding in conscious rats. Brain Res. 1988 Dec 6;474(2):399–402. doi: 10.1016/0006-8993(88)90459-3. [DOI] [PubMed] [Google Scholar]
  22. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  23. Persson M. G., Wiklund N. P., Gustafsson L. E. Nitric oxide requirement for vasomotor nerve-induced vasodilatation and modulation of resting blood flow in muscle microcirculation. Acta Physiol Scand. 1991 Jan;141(1):49–56. doi: 10.1111/j.1748-1716.1991.tb09043.x. [DOI] [PubMed] [Google Scholar]
  24. Rees D. D., Palmer R. M., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990 Nov;101(3):746–752. doi: 10.1111/j.1476-5381.1990.tb14151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Saeki Y., Sato A., Sato Y., Trzebski A. Stimulation of the rostral ventrolateral medullary neurons increases cortical cerebral blood flow via activation of the intracerebral neural pathway. Neurosci Lett. 1989 Dec 15;107(1-3):26–32. doi: 10.1016/0304-3940(89)90785-4. [DOI] [PubMed] [Google Scholar]
  26. Sakuma I., Togashi H., Yoshioka M., Saito H., Yanagida M., Tamura M., Kobayashi T., Yasuda H., Gross S. S., Levi R. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. A role for nitric oxide in the central regulation of sympathetic tone? Circ Res. 1992 Mar;70(3):607–611. doi: 10.1161/01.res.70.3.607. [DOI] [PubMed] [Google Scholar]
  27. Seligsohn E. E. Adrenergic and non-adrenergic cardiovascular effects of thyrotropin-releasing hormone (TRH) in the anaesthetized rabbit. Acta Physiol Scand. 1992 Sep;146(1):107–117. doi: 10.1111/j.1748-1716.1992.tb09398.x. [DOI] [PubMed] [Google Scholar]
  28. Seligsohn E. E., Koskinen L. O. Effects of alpha 2-adrenoceptor blockade and thyrotropin-releasing hormone (TRH) on the cardiovascular system in the rabbit. Acta Physiol Scand. 1991 Oct;143(2):187–194. doi: 10.1111/j.1748-1716.1991.tb09220.x. [DOI] [PubMed] [Google Scholar]
  29. Sirén A. L., Lake C. R., Feuerstein G. Hemodynamic and neural mechanisms of action of thyrotropin-releasing hormone in the rat. Circ Res. 1988 Jan;62(1):139–154. doi: 10.1161/01.res.62.1.139. [DOI] [PubMed] [Google Scholar]
  30. Tanaka K., Gotoh F., Gomi S., Takashima S., Mihara B., Shirai T., Nogawa S., Nagata E. Inhibition of nitric oxide synthesis induces a significant reduction in local cerebral blood flow in the rat. Neurosci Lett. 1991 Jun 10;127(1):129–132. doi: 10.1016/0304-3940(91)90911-c. [DOI] [PubMed] [Google Scholar]
  31. Toda N., Okamura T. Role of nitric oxide in neurally induced cerebroarterial relaxation. J Pharmacol Exp Ther. 1991 Sep;258(3):1027–1032. [PubMed] [Google Scholar]
  32. Uddman R., Edvinsson L. Neuropeptides in the cerebral circulation. Cerebrovasc Brain Metab Rev. 1989 Fall;1(3):230–252. [PubMed] [Google Scholar]
  33. Wang Q., Paulson O. B., Lassen N. A. Is autoregulation of cerebral blood flow in rats influenced by nitro-L-arginine, a blocker of the synthesis of nitric oxide? Acta Physiol Scand. 1992 Jul;145(3):297–298. doi: 10.1111/j.1748-1716.1992.tb09368.x. [DOI] [PubMed] [Google Scholar]
  34. Yao K., Tschudi M., Flammer J., Lüscher T. F. Endothelium-dependent regulation of vascular tone of the porcine ophthalmic artery. Invest Ophthalmol Vis Sci. 1991 May;32(6):1791–1798. [PubMed] [Google Scholar]
  35. Yarbrough G. G. On the neuropharmacology of thyrotropin releasing hormone (TRH). Prog Neurobiol. 1979;12(3-4):291–312. doi: 10.1016/0301-0082(79)90012-1. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES